BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization.
about
Absence of Ret signaling in mice causes progressive and late degeneration of the nigrostriatal systemAlterations in postnatal neurogenesis and dopamine dysregulation in schizophrenia: a hypothesisWhat can rodent models tell us about apathy and associated neuropsychiatric symptoms in Parkinson's disease?Genetic, transcriptomic, and epigenetic studies of HIV-associated neurocognitive disorderNeurotrophins in the ventral tegmental area: Role in social stress, mood disorders and drug abuseThe transfection of BDNF to dopamine neurons potentiates the effect of dopamine D3 receptor agonist recovering the striatal innervation, dendritic spines and motor behavior in an aged rat model of Parkinson's diseaseMaking Sense of: Sensitization in SchizophreniaCorticostriatal BDNF and alcohol addictionRole of phosphatidylinositide 3-kinase in brain-derived neurotrophic factor-induced DARPP-32 expression in medium size spiny neurons in vitroThe neurobiology of dopamine receptors: evolution from the dual concept to heterodimer complexesTranslating neurobehavioural endpoints of developmental neurotoxicity tests into in vitro assays and readoutsDevelopmental and adult expression patterns of the G-protein-coupled receptor GPR88 in the rat: Establishment of a dual nuclear-cytoplasmic localizationThe longitudinal and interactive effects of HIV status, stimulant use, and host genotype upon neurocognitive functioning.The role of host genetics in the susceptibility for HIV-associated neurocognitive disorders.Functional polymorphisms in dopamine-related genes: effect on neurocognitive functioning in HIV+ adults.A new nosology of psychosis and the pharmacological basis of affective and negative symptom dimensions in schizophrenia.Selective overexpression of dopamine D3 receptors in the striatum disrupts motivation but not cognition.Drug-induced activation of dopamine D(1) receptor signaling and inhibition of class I/II histone deacetylase induce chromatin remodeling in reward circuitry and modulate cocaine-related behaviorsEthanol-BDNF interactions: still more questions than answers.BDNF-dependent stimulation of dopamine D5 receptor expression in developing striatal astrocytes involves PI3-kinase signaling.Motor deficits and altered striatal gene expression in aphakia (ak) mice.Reducing aggression and impulsivity through school-based prevention programs: a gene by intervention interaction.The brain-derived neurotrophic factor receptor TrkB is critical for the acquisition but not expression of conditioned incentive value.Parental brain-derived neurotrophic factor genotype, child prosociality, and their interaction as predictors of parents' warmthBrain-derived neurotrophic factor regulates hedonic feeding by acting on the mesolimbic dopamine systemDopamine D3 receptor is necessary for ethanol consumption: an approach with buspironeChanges in Expression of Dopamine, Its Receptor, and Transporter in Nucleus Accumbens of Heroin-Addicted Rats with Brain-Derived Neurotrophic Factor (BDNF) Overexpression.Implication of dopamine D3 receptor activation in the reversion of Parkinson's disease-related motivational deficits.Decreased BDNF in patients with antipsychotic naïve first episode schizophrenia.The role of transcription factor Pitx3 in dopamine neuron development and Parkinson's disease.A functional fast scan cyclic voltammetry assay to characterize dopamine D2 and D3 autoreceptors in the mouse striatum.Dopamine modulates cell cycle in the lateral ganglionic eminence.The brain-derived neurotrophic factor enhances synthesis of Arc in synaptoneurosomes.Genetics of Opioid Dependence: A Review of the Genetic Contribution to Opioid Dependence.Blockade of dopamine D₃ but not D₂ receptors reverses the novel object discrimination impairment produced by post-weaning social isolation: implications for schizophrenia and its treatment.Dopamine receptor alterations in female rats with diet-induced decreased brain docosahexaenoic acid (DHA): interactions with reproductive status.Genetic variants in the BDNF gene and therapeutic response to risperidone in schizophrenia patients: a pharmacogenetic study.BDNF in schizophrenia, depression and corresponding animal models.Clinical significance of pharmacogenomic studies in tardive dyskinesia associated with patients with psychiatric disordersDopamine systems adaptation during acquisition and consolidation of a skill.
P2860
Q21090220-48F319D6-EA5B-41BB-AA8B-A3FD50DB7F5CQ24606423-DB9578E6-134A-4874-8E56-77A2900D9E74Q26767268-99471D58-4ED8-4C79-9128-9E819A3100EAQ26865707-4EC9473E-B961-47F0-A911-3EB6B46D8AA3Q26991923-30825061-AC71-4D44-9B68-D12A0ED7A76EQ27316252-91C82B8B-6A33-4513-8CF8-5A757F06D701Q28077939-7B21373E-994B-454C-814D-936FEA529049Q28083756-95CDDEE0-B1F1-46AF-A8F5-5A398CA57E1EQ28210065-F01F8A93-F1C7-451D-8033-3330321F8BE0Q28289714-856FE51C-E694-4515-82F1-0634FB407181Q28397001-FCEB8624-C88D-4925-9F36-94136246A587Q28573244-740B46D1-7809-4FCD-9779-5EE75939933AQ30410418-0CB892D1-B711-42D2-AF1A-6913CCD0D2F1Q30411844-B125FB46-7324-487A-AE24-1E944D6924DCQ30416710-0A408473-52F3-4FC9-AA99-A2953C5C18D5Q30423651-C82FA2AB-E528-4909-B11E-8B9F4939AC4CQ30423688-6D1B51A0-7A77-4FE4-ACB7-0C2003DA7E17Q30490304-E62A4437-DCA9-4FEA-827D-2CAB6D873ACDQ30490427-1128F355-F5E6-496F-B7F7-3FDFC684D797Q33200407-C9E0FC91-10F9-40FD-8E56-CA8C935AD7B7Q33303267-C6DF8CA6-820A-4EDF-9617-31E28DF88D3CQ33555950-0839B701-2583-41C0-B3B8-76A192EE8B3CQ33671912-7CBA9283-A11D-4F36-82F5-1747F65750BDQ33695338-7A4BB118-A332-41A5-91D1-96683D3A7572Q33758309-C81DB6D8-4F8B-497D-A082-97B30D017F9DQ33764334-310E7C6E-EA88-4F29-B580-8E5AA67880F2Q33806426-542C2A94-2181-49E6-809E-51DAC970E86CQ33840503-6D7F4A14-235A-4D34-9D0D-E520E7547041Q33847022-E254C01A-2905-4C23-9C61-E0B0B00DBFD6Q33861795-4DF42EB6-FC3E-4628-858A-D8D3CF8CA92AQ33921257-51B97BC9-BF2E-4742-B971-C8CEE1337DC2Q33947268-B5AD526A-F929-4DD1-88B8-CD4945B43172Q34013346-AF42460B-B04E-4C87-9DBB-7AE2E0EC123BQ34139876-E5D859F6-B27B-4507-9FB4-96C0A0B783ECQ34171445-0FD6B30C-463B-4DD7-B11A-517A91491176Q34202220-980F3001-E49E-46A2-A2EB-3C97BC084987Q34329113-89C181BC-7AB6-4924-98B7-9289E40D4857Q34385320-57535DBB-F40F-445B-9063-55DBD6971F19Q34391577-1D11A4FA-ED5C-4D7F-A53C-6A053F6F2E4DQ34454637-A043F57A-1AEC-49A8-BC7D-DBB9FA54CA30
P2860
BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization.
@ast
BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization.
@en
type
label
BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization.
@ast
BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization.
@en
prefLabel
BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization.
@ast
BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization.
@en
P2093
P2860
P356
P1433
P1476
BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization.
@en
P2093
P2860
P2888
P356
10.1038/35075076
P407
P577
2001-05-01T00:00:00Z
P5875
P6179
1031257159